These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9041760)

  • 21. Effects of double filtration plasmapheresis on nocturnal respiratory function in myasthenic patients.
    Yeh JH; Lin CM; Chen WH; Chiu HC
    Artif Organs; 2013 Dec; 37(12):1076-9. PubMed ID: 23865547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Efficacy of Double-Filtration Plasmapheresis in Treating Five Patients With Drug-Resistant Pemphigus.
    Higashihara T; Kawase M; Kobayashi M; Hara M; Matsuzaki H; Uni R; Matsumura M; Etoh T; Takano H
    Ther Apher Dial; 2017 Jun; 21(3):243-247. PubMed ID: 28661097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-filtration plasmapheresis for treatment of acute renal failure in a multiple myeloma patient.
    Jiang X; Feng J; Ye Y
    Ther Apher Dial; 2014 Jun; 18(3):318-9. PubMed ID: 24820823
    [No Abstract]   [Full Text] [Related]  

  • 24. A case report of double-filtration plasmapheresis for the treatment of age-related macular degeneration.
    Yeh JH; Cheng CK; Chiu HC
    Ther Apher Dial; 2008 Dec; 12(6):500-4. PubMed ID: 19140849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
    Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
    J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic plasmapheresis using membrane plasma separation.
    Sinha A; Tiwari AN; Chanchlani R; Seetharamanjaneyulu V; Hari P; Bagga A
    Indian J Pediatr; 2012 Aug; 79(8):1084-6. PubMed ID: 22766901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].
    Tatay J; Díez-Tejedor E; Frank A; Tejada J; Marrero C; Barreiro P
    Rev Neurol; 1997 Sep; 25(145):1402-6. PubMed ID: 9377299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments.
    Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G
    Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776
    [No Abstract]   [Full Text] [Related]  

  • 29. Double filtration plasmapheresis in different diseases in Thailand.
    Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
    Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia.
    Galán Carrillo I; Demelo-Rodriguez P; Rodríguez Ferrero ML; Anaya F
    J Clin Lipidol; 2015; 9(5):698-702. PubMed ID: 26350817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
    J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.
    Yeh JH; Chen WH; Chiu HC; Bai CH
    J Neurol Sci; 2007 Dec; 263(1-2):191-3. PubMed ID: 17602704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmapheresis therapy in renal transplant patients: five-year experience.
    Gungor O; Sen S; Kircelli F; Yilmaz M; Sarsik B; Ozkahya M; Hoscoskun C; Ok E; Toz H
    Transplant Proc; 2011 Apr; 43(3):853-7. PubMed ID: 21486614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome.
    Lin JH; Tu KH; Chang CH; Chen YC; Tian YC; Yu CC; Hung CC; Fang JT; Yang CW; Chang MY
    Transfus Apher Sci; 2015 Feb; 52(1):78-83. PubMed ID: 25544386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications in patients treated with plasmapheresis in the intensive care unit.
    Szczeklik W; Wawrzycka K; Włudarczyk A; Sega A; Nowak I; Seczyńska B; Fajfer I; Zając K; Królikowski W; Kózka M
    Anaesthesiol Intensive Ther; 2013; 45(1):7-13. PubMed ID: 23572301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of plasmapheresis refractory thrombotic thrombocytopenic purpura with double-filtration membrane plasmapheresis.
    Karakus V; Deveci B; Kurtoğlu E
    Transfus Apher Sci; 2013 Jun; 48(3):313-4. PubMed ID: 23631953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasmapheresis, a safe treatment when applied to the correct indication and with awareness of the complications].
    Pruijm MT; Vogt B; Cherpillod A; Burnier M
    Ned Tijdschr Geneeskd; 2008 Oct; 152(42):2261-6. PubMed ID: 19009872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis.
    Yeh JH; Wang SH; Chien PJ; Shih CM; Chiu HC
    Eur J Neurol; 2009 Dec; 16(12):1318-22. PubMed ID: 19614971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.